Pivotal Phase 2/3 study is being conducted in collaboration with Children’s Oncology Group DUBLIN, Dec. 30, 2019 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in the pivotal Phase 2/3...
A newly approved Chinese drug for Alzheimer’s will start clinical trials in the US and Europe next year as the country’s first novel therapy for the incurable disease seeks global legitimacy. Shanghai Green Valley Pharmaceutical Co. plans to recruit around 2,046...
Santa Ana, CA — (SBWIRE) — 12/30/2019 — Technological advancements have allowed medicial sciences to flourish. More and more studies are being conducted on a daily basis to discover novel ways of preventing, detecting, diagnosing, controlling, and...
INDIANAPOLIS, Dec. 30, 2019 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced the opening of the LIBRETTO-531 clinical trial [NCT04211337] for selpercatinib, also known as LOXO-292, for treatment-naïve RET-mutant medullary thyroid cancer (MTC)...
SOUTH SAN FRANCISCO, Calif., Dec. 30, 2019 (GLOBE NEWSWIRE) — Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with significant unmet medical needs in immune-mediated...
Email
Text